Topamax Birth DefectsCleft Lip and Cleft Palate
Cleft lip and cleft palate are variations of a type of congenital deformity caused by abnormal facial development during gestation. A cleft is a fissure or opening—a gap. An older term for cleft lip is harelip.
Cleft lip and palate birth defects can increase the risk of ear infections and cause problems eating and communicating. A cleft lip or palate can be successfully treated with surgery, especially if conducted soon after birth or in early childhood.Topamax Birth Defects
According to a scientific study published by the American Academy of Neurology in April 2008, taking Topamax significantly increases the risk of cleft lip and palate birth defects. The published study reviewed 203 pregnancies. Overall, the rate of oral clefts observed was 11 times more prevalent than the normal rate.
Approximately 1 in 700 infants are born with a cleft lip and/or a cleft palate. Therefore, the normal rate of cleft palates is 0.0014 percent. However, according to this study, persons taking Topamax during pregnancy had a cleft palate rate of 0.0157 percent – 11 times the normal rate of congenital malformations.
Due to these and other serious side effects, the United States Food and Drug Administration (FDA) issued additional warnings for Topamax. The warning was raised to Pregnancy Category D, which means there is positive evidence of human fetal risk.Contact a Proven Law Firm
If your child is suffering from a congenital deformity, it may be due to Topamax. At O’Hanlon, McCollom & Demerath, we stand ready to hold these drug manufacturers accountable for the dangerous side effects of Topamax. Contact our law firm today for a free consultation – we may be able to obtain compensation for your child’s injuries.